BioCryst Pharmaceuticals, Inc.
Biotechnology-Research
Website
Company Tagline
We develop oral small-molecule and protein therapeutics to target complement-mediated and other rare diseases.
Industry Category
Business Keywords
Company Description
BioCryst Pharmaceuticals, Inc. is a global biotechnology company dedicated to enhancing the lives of individuals affected by complement-mediated and other rare diseases. With a strong focus on structure-guided drug design, BioCryst Pharmaceuticals excels in developing first-in-class and best-in-class oral small-molecule and protein therapeutics aimed at addressing challenging-to-treat conditions. The company's innovative approach positions it as a leader in the biotechnology sector.
Based in Durham, NC, at 4505 Emperor Blvd., Suite 200, Durham, NC 27703, US, BioCryst Pharmaceuticals operates with a global perspective, with additional locations including 2100 Riverchase Center, Birmingham, Alabama 35244, US, and Dublin, IE. BioCryst Pharmaceuticals leverages the collective expertise of its colleagues worldwide, from field operations to laboratory research, ensuring a comprehensive and impactful approach to drug development and commercialization. The company's commitment to innovation and patient care drives its continuous growth and success.
BioCryst Pharmaceuticals' dedication to regulatory affairs, clinical development, and product commercialization solidifies its role as a key player in the biotechnology landscape. The company is constantly advancing its research and development efforts to bring novel therapies to market. We invite the manager of BioCryst Pharmaceuticals, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and innovations.
BioCryst Pharmaceuticals, Inc. est une société mondiale de biotechnologie dédiée à l'amélioration de la vie des personnes touchées par des maladies à médiation complémentaire et d'autres maladies rares. En mettant l'accent sur la conception de médicaments guidée par la structure, BioCryst Pharmaceuticals excelle dans le développement de petites molécules orales et de protéines thérapeutiques, premières de leur catégorie et les meilleures de leur catégorie, visant à traiter des affections difficiles à soigner. L'approche innovante de l'entreprise la positionne comme un leader dans le secteur de la biotechnologie.
Basée à Durham, Caroline du Nord, au 4505 Emperor Blvd., Suite 200, Durham, Caroline du Nord 27703, États-Unis, BioCryst Pharmaceuticals opère dans une perspective mondiale, avec des sites supplémentaires, notamment 2100 Riverchase Center, Birmingham, Alabama 35244, États-Unis, et Dublin, IE. BioCryst Pharmaceuticals tire parti de l'expertise collective de ses collègues du monde entier, des opérations sur le terrain à la recherche en laboratoire, garantissant ainsi une approche globale et percutante du développement et de la commercialisation de médicaments. L'engagement de l'entreprise envers l'innovation et les soins aux patients est le moteur de sa croissance et de son succès continus.
L'engagement de BioCryst Pharmaceuticals en faveur des affaires réglementaires, du développement clinique et de la commercialisation de produits conforte son rôle d'acteur clé dans le paysage biotechnologique. L'entreprise fait constamment progresser ses efforts de recherche et de développement pour commercialiser de nouvelles thérapies. Nous invitons le responsable de BioCryst Pharmaceuticals, Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur vos réalisations et vos innovations.
Key Personnel / Employees
Compare Companies Side by Side
Compare BioCryst Pharmaceuticals, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
BioCryst Pharmaceuticals,...Main Company |
Syngene Internationa...View Profile |
Kyowa Kirin Internat...View Profile |
SynapmedView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1993 | 1995 | 2020 |
|
Company Size
|
— | 5,001-10,000 | 501-1,000 | 51-200 |
|
City
|
Durham, NC | Bengaluru, Karnataka | Galashiels, Selkirkshire | |
|
Country
|
United States | India | ||
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Pharmaceuticals
Drug Development
Rare Diseases
Therapeutics
Clinical Research
Drug Discovery
Regulatory Affairs
Clinical Development
Product Commercialization
|
30 Total
1 Common
29 Unique
Match
10%
Common Skills:
Drug Development
Unique Skills:
Analytical Characterization & Quality Control
Analytical Development
Antibody Drug Conjugates
Antibody Generation
Bioanalytical Laboratory Services
Biologics
+23
|
11 Total
2 Common
9 Unique
Match
20%
Common Skills:
Biotechnology
Pharmaceuticals
Unique Skills:
Antibodies
Biopharmaceuticals
Central Nervous System
Hematology / Haematology
Nephrology
Neurology
+3
|
8 Total
1 Common
7 Unique
Match
10%
Common Skills:
Drug Development
Unique Skills:
Artificial Intelligence
Commercialization
Medical Affairs
Medical Information
Pharmacovigilance
Predictive Analytics
+1
|
4
Total Companies1993
Oldest Founded2
Countries55
Unique SkillsSimilar Companies
Other organizations in the same industry
Myosin Therapeutics Inc.
Biotechnology-ResearchDeveloping next generation therapeutics targeting molecular motors
Bionamic AB
Biotechnology-ResearchThe SaaS dedicated to antibody R&D data. Deeper insight, faster results and full traceability.
Alternative Company Names
This company is also known as